Frankfurt (10 May 2021) – Today, MV Index Solutions GmbH (MVIS®) announced the licensing of the BlueStar Genomic Health Care Index (ticker: BDNANTR) to Migdal Mutual Funds,a leading Israeli issuer of ETFs and index mutual funds for their second product on this index.
The BlueStar Genomic Health Care Index (ticker: BDNANTR) providesexposure to globally listed ‘Genomic Health Care’ companies, the companiesmust derive 50% of revenue or product pipeline from: health care therapiesbased on the targeting or modifying of genetic makeup of cells, technologyplatforms that enable the development of gene editing, or laboratory equipmentor services used to test, code or develop gene editing.
The BlueStar Genomic Health Care Index (ticker: BDNANTR) is calculated in US Dollars as a totalreturn net index. Detailed information about each index is available on MV Index Solutions website.
Get the latest news & insights from MarketVector
Get the newsletterRelated:
Most popular
-
-21.webp)
Commentarytesting insight for UAT
-
-20.webp)
CommentaryTesting 3
-
CommentaryTesting 18 July